FDA approves hair-growth medicine that can be used to treat alopecia and Covid
On Monday, the Food and Medicine Administration approved a drug to treat severe alopecia, a condition that affects more than 300,000 Americans each year. The FDA said in a news release on Tuesday that the approval of Olumiant (baricitinib) was significant since it is the first treatment approved by the government that addresses the autoimmune…